N/A
N=200
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
Diabetes Mellitus · Bipolar Disorder · Depression · Psychotic Disorders · Schizophrenia
Bottom Line
View on ClinicalTrials.gov: NCT01410357 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Oct 2017
Primary outcome: Primary: Brief Psychiatric Rating Scale (BPRS) at 60 Weeks — 32.04; 35.89 scores on a scale — p=.785
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Targeted Training in Illness Management (TTIM) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Case Western Reserve University
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Brief Psychiatric Rating Scale (BPRS) at 60 Weeks |
32.04; 35.89 | .785 |
| PRIMARY Montgomery Asberg Depression Rating Scale (MADRS) at 60 Weeks |
15.92; 18.55 | .016 sig |
| PRIMARY Clinical Global Impression (CGI) at 60 Weeks |
3.24; 4.03 | <0.001 sig |
| PRIMARY Global Assessment of Functioning (GAF) at 60 Weeks |
61.05; 53.29 | .003 sig |
| PRIMARY Sheehan Disability Scale (SDS) at 60 Weeks |
15.0; 16.47 | .086 |
| PRIMARY SF-36 (Short-form) Health Survey at 60 Weeks; Mental Health Component |
42.05; 39.58 | .872 |
| PRIMARY Glycosylated Hemoglobin (HbA1c) at 60 Weeks |
7.69; 7.77 | .662 |
| PRIMARY Systolic Blood Pressure at 60 Weeks |
134.12; 132.71 | .633 |
| PRIMARY Body Mass Index (BMI) at 60 Weeks |
36.46; 37.07 | .175 |
| PRIMARY SF-36 Health Survey at 60 Weeks; Physical Health Component |
39.65; 40.81 | .680 |
| SECONDARY Tablets Routine Questionnaire (TRQ) at 60 Weeks |
17.09; 18.65 | .407 |
| SECONDARY Self-rated Diabetes Self-Care Activities (SDSCA) Questionnaire at 60 Weeks |
47.69; 48.28 | .870 |
| SECONDARY Comparison of AUDIT (Alcohol Use Disorders Identification Test) Score Between TTIM and TAU (Treatment as Usual) at 60 Weeks |
1.93; 1.16 | .707 |
| SECONDARY Comparison of ISMI (Internalized Stigma of Mental Illness -Alienation) Between TTIM and TAU at 60 Weeks |
15.41; 15.55 | .838 |
| SECONDARY Comparison of ISMI (Stereotype Endorsement) Score Between TTIM and TAU at 60 Weeks |
13.80; 13.92 | .853 |
| SECONDARY Comparison of ISMI (Discrimination Experience) Between TTIM and TAU at 60 Weeks |
12.63; 12.31 | .853 |
| SECONDARY Comparison of ISMI (Social Withdrawal) Score Between TTIM and TAU at 60 Weeks |
14.50; 13.85 | .510 |
| SECONDARY Comparison of ISMI (Stigma Resistance) Score Between TTIM and TAU at 60 Weeks |
5.84; 6.47 | .573 |
Summary
This project tests a model for improving illness self-management among persons who have both serious mental illness and diabetes and will be performed within a primary care setting at a safety net hospital system. The information gained from the randomized trial will be supplemented with reports from participants about their experiences of trying to improve illness self-management. Improvements in self-management should result in a reduction of psychiatric symptoms and improvements in functioning and physical health.
Eligibility Criteria
Inclusion Criteria
- Have Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder or major depression
- Have DM based upon either previous diagnosis or laboratory values
- Be ≥ 18 years of age
- Be able to communicate in English
- Be able to provide written, informed consent to participation.
Exclusion Criteria
- Actively suicidal/homicidal
- Unable to be rated on study rating scales
- Demented
- Pregnant
- Unable to provide informed consent.
Data sourced from ClinicalTrials.gov (NCT01410357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.